Denis Jullien Selected Research

Dermatomyositis (Dermatopolymyositis)

12/2021	TRIM33 gene somatic mutations identified by next generation sequencing in neoplasms of patients with anti-TIF1γ positive cancer-associated dermatomyositis.
1/2019	The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Denis Jullien Research Topics

Disease

15	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 08/2012
8	Neoplasms (Cancer) 12/2023 - 03/2009
5	Inflammation (Inflammations) 01/2023 - 01/2020
3	Pemphigus (Pemphigus Vulgaris) 01/2024 - 05/2017
3	Melanoma (Melanoma, Malignant) 11/2021 - 10/2010
2	Acrodermatitis (Gianotti Crosti Syndrome) 12/2023 - 01/2015
2	Infections 12/2023 - 01/2021
2	COVID-19 01/2023 - 01/2021
2	Dermatomyositis (Dermatopolymyositis) 12/2021 - 01/2019
2	Skin Neoplasms (Skin Cancer) 04/2017 - 08/2014
1	Drug Hypersensitivity Syndrome 01/2024
1	Acquired Hyperostosis Syndrome (SAPHO Syndrome) 12/2023
1	Candidiasis (Moniliasis) 12/2023
1	Pain (Aches) 02/2023
1	Wells syndrome 01/2023
1	Pruritus (Itching) 01/2023
1	Skin Manifestations 01/2023
1	Myocardial Infarction 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022
1	Immune System Diseases (Immune Disorders) 12/2021
1	Obesity 01/2021
1	Blister (Bulla) 01/2021
1	Onycholysis 01/2021
1	Chilblains (Chilblain) 01/2020
1	Edema (Dropsy) 01/2020
1	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2020
1	Histiocytosis 01/2020
1	Acanthoma 04/2019
1	Pityriasis Rubra Pilaris 01/2019
1	Psoriatic Arthritis 10/2017
1	Genetic Predisposition to Disease (Genetic Predisposition) 10/2017
1	Pathologic Complete Response 05/2017
1	Muscular Diseases (Myopathy) 05/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2017
1	Vasculitis (Vasculitides) 02/2015
1	Necrosis 01/2015
1	Hidradenitis Suppurativa 11/2014
1	Alopecia Areata 06/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2012
1	Genomic Instability 03/2012
1	Breast Neoplasms (Breast Cancer) 10/2010
1	Neoplasm Metastasis (Metastasis) 10/2010

Drug/Important Bio-Agent (IBA)

4	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 05/2017
4	apremilastIBA 09/2023 - 03/2022
4	AntibodiesIBA 01/2019 - 01/2015
3	Rituximab (Mabthera)FDA Link 01/2024 - 05/2017
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
2	ChemokinesIBA 01/2023 - 10/2010
2	AutoantibodiesIBA 12/2021 - 01/2019
2	Acitretin FDA Link 01/2019 - 01/2015
2	Tacrolimus (Prograf)FDA LinkGeneric 11/2014 - 08/2014
2	Phosphotransferases (Kinase)IBA 03/2012 - 01/2002
2	cdc25 PhosphatasesIBA 04/2009 - 03/2009
1	Omalizumab (Xolair)FDA Link 01/2024
1	Immunoglobulin A (IgA)IBA 12/2023
1	Antifungal AgentsIBA 12/2023
1	bimekizumabIBA 12/2023
1	tildrakizumabIBA 12/2023
1	Interleukin-13IBA 01/2023
1	baricitinibIBA 01/2023
1	RNA (Ribonucleic Acid)IBA 01/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2023
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Methotrexate (Mexate)FDA LinkGeneric 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 12/2021
1	IA 4IBA 11/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2021
1	Cladribine FDA LinkGeneric 01/2020
1	EnzymesIBA 01/2020
1	FibrinIBA 01/2020
1	ImmunosorbentsIBA 01/2020
1	Infliximab (Remicade)FDA Link 01/2020
1	DesmogleinsIBA 01/2020
1	ixekizumabIBA 01/2019
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	beta CateninIBA 08/2018
1	Calbindin 2IBA 08/2018
1	Immunologic Factors (Immunomodulators)IBA 10/2017
1	Prednisone (Sone)FDA LinkGeneric 05/2017
1	Azathioprine (Imuran)FDA LinkGeneric 04/2017
1	Ustekinumab (CNTO 1275)FDA Link 01/2015
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 01/2015
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2014
1	VaccinesIBA 08/2012
1	3- (carbamoylamino)- 5- (3- fluorophenyl)- N- (3- piperidyl)thiophene- 2- carboxamideIBA 03/2012
1	LigandsIBA 10/2010
1	Chemokine CCL21IBA 10/2010
1	Antineoplastic Agents (Antineoplastics)IBA 04/2009

Therapy/Procedure

12	Therapeutics 01/2024 - 03/2009
3	Liver Transplantation 04/2019 - 08/2014
2	Organ Transplantation 11/2021 - 11/2017
2	Transplantation 11/2021 - 04/2017
2	Biological Therapy 01/2021 - 01/2015
2	Kidney Transplantation 04/2017 - 11/2014
1	Contraindications 02/2023
1	Colectomy 01/2022
1	Emergency Treatment 01/2022
1	Aftercare (After-Treatment) 01/2020